Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.

Oncotarget

Volumn 1, Issue 7, 2010, Pages 628-638

  Powe, Desmond G ^a   Voss, Melanie J ^b   Zänker, Kurt S ^b   Habashy, Hany O ^b   Green, Andrew R ^b   Ellis, Ian O ^b   Entschladen, Frank ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BREAST TUMOR; CARCINOMA; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG EFFECT; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79953658412     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.197     Document Type: Article

References (0)